Procedures for IgG depletion in visceral leishmaniasis (VL) 
Immunoglobulin E is an isotype of antibody that has Fc receptors of different affinity on basophils, mast cells, eosinophils, macrophages and platelets. The immune reaction of IgE fixed on these cells with the corresponding antigen can release bioactive cell mediators as histamine, sulfidopeptide leukotrienes, prostaglandin D 2 or plateletactivating factor, causing systemic or local inflammatory reactions. The involvement of IgE in host immune response to parasite antigens was showed immediately after its immunochemical identification in 1969, when high concentration of this protein in serum was obtained from persons suffering of helminthiasis (Bennich et al. 1969 , Kojima et al. 1972 . The recent studies on the dichotomy of immune response in Th1 and Th2 (Coffman et al. 1991) , which is related to the pattern of cytokines produced during antigenic stimulation, have shown that IgE is the mainly antibody induced by IL-4 and IL-13 during a Th2 immunologic event (Romagnani 1998 , 2000 , Hunter & Reiner 2000 . This fact has provoked the interest in the research of this isotype of immunoglobulin in several diseases associated to a Th2 immunological pattern such as systemic lupus erythematosus and viral and parasitic infections (Elkayam et al. 1995 , Mazza et al. 1995 , Atta et al. 1998 . A common pitfall in serum IgE immunoassays to diagnosis infections by protozoa or helminth, also present in IgM tests, corresponds to false negative results originated by serologic competition of IgG antibodies, generally present in greater concentration, and affinity for common epitopes on target antigens. In order to solve this problem, procedures of serum IgG depletion have been advised, employing antihuman IgG antibodies obtained through immunization of different species, followed by elimination of the immune precipitates formed after absorption by centrifugation. Recently, when we investigated the occurrence of IgE anti-Leishmania chagasi antibodies in sera from patients with visceral leishmaniasis (VL), and also IgE anti-Schistosoma mansoni antibodies in sera from individuals with schistosomiasis, we observed that the use of Sepharoseprotein G for the depletion of IgG caused significant fall in sensitivity of the specific immunoassays when the results obtained were compared with those derived from the use of RF-Absorbent (Behring Diagnostics, USA), a solution of purified anti-human IgG antibodies (Sousa- Atta et al. 1999) . Considering that IgG anti-IgE autoantibodies have been demonstrated in healthy individuals and in patients with asthma, autoimmune and parasite diseases (Inganas et al. 1981 , Quinti et al. 1986 , Gruber et al. 1988 , Scheuer et al. 1991 , and complexed IgG anti-IgE autoantibodies were documented in sera from Crohn's disease patients and from patients with rheumatoid arthritis (Huber et al. 1998 , Millauer et al. 1999 , the aims of this study was to evaluate the levels of complexed IgG anti-IgE autoantibodies in sera from VL and from with hepatic-intestinal schistosomiasis mansoni patients and also to investigate if treatment of human serum with Sepharose-Protein G causes IgE depletion through the sequestration of immunocomplexes IgGIgE by the beads.
MATERIALS AND METHODS
Sera -Sera from 10 VL and 10 schistosomiasis mansoni patients were obtained from persons with clinical and laboratory diagnosis of these parasitic diseases, all assisted by the staff of the Immunology Service of the Hospital Universitário Professor Edgard Santos. Control sera were from 10 healthy individuals having negative serology for rheumatic and infectious diseases (American trypanosomiasis, viral hepatitis and syphilis).
Methods -The immunoassay to detect complexed IgG anti-IgE autoantibodies was an ELISA of immunocapture of IgE, developed on polystyrene microplates containing wells covered with goat IgG anti-IgE (Sigma Chemical Co., USA) and a goat IgG anti-human IgG peroxidase conju-gate, from the same source, to demonstrate the immunecomplexes IgG-IgE captured. Briefly, the immune reaction to capture IgE was performed incubating 100 µl of human sera diluted at 1/6 in 50 mM Tris-HCl (pH 7.5) buffered-saline containing 1% bovine serum albumine and 0.05% Tween 20 for 1 h at room temperature, while the reaction with 100 µl of the diluted conjugate was developed in the same conditions, after wash of the wells. The reactions were revealed with hydrogen peroxide plus OPD (ortho-phenylenediamine) during 30 min, stopped with 2N HCl and determined at 492-600 nm in a DIAMEDIX BP-12 Microassay apparatus.
To demonstrate the sequestration of complexed IgG anti-IgE by protein G, three sera from each group under study were diluted at 1/5 in PBS containing 25% of Sepharose-protein G (Pharmacia Biotech, Uppsala, Sweden) and incubated during 15 min at room temperature. After repeated wash by centrifugation with PBS, the beads were treated with SDS-polyacrylamide gel electrophoresis sample buffer containing 2-mercaptoethanol to elute the captured material, followed by electrophoresis on a 10% acrylamide minigel. The polypeptides fractionated were transferred by electrophoresis to a PVDF membrane (Immobilon, Millipore, and USA) and analyzed for IgE by incubation with goat anti-human IgE peroxidase conjugated (Sigma Chemical Co., USA). After new wash, the immune reactions were revealed incubating the membrane with hydrogen peroxide plus DAB (3,3´-diaminobenzidine), as usually.
Serum IgE concentration was determined by ELFA using the Vidas 30 immunoanalyzer from biolabMeriéux.
Statistical analysis were performed through the Primer PC statistic program using a non-parametric test U of MannWhitney.
RESULTS
Complexed IgG anti-IgE autoantibodies were detected in all sera studied. The results of the immunoassays to detect these immune complexes are presented in the Fig. 1 . While schistosomiasis and normal sera presented similar titers, sera from VL patients had higher levels of complexed IgG anti-IgE when compared to these groups, as assessed by the U test of Mann-Whitney (p < 0.05). There was no correlation between IgE concentration and complexed IgG anti-IgE level in serum (p > 0.05). Patients from schistosomiasis group with serum IgE concentration of 97 IU/ml or 5800 IU/ml presented similar levels of complexed IgG antiIgE autoantibodies.
Immunochemical analysis carried out with material eluted from batching experiments to deplete IgG from these sera evidenced significant capture of IgE immunoglobulin during IgG binding to Sepharose protein G beads, as demonstrated by intense brown colored band on PVDF membrane, with molecular weight corresponding to 75 kDa IgE heavy chain in all sera analyzed, inclusive from healthy controls. Other peptides of different weights that probably correspond to the products of physiologic degradation of this immunoglobulin were also observed (Fig. 2) . However, only visceral leishmaniasis sera presented an additional polypeptide with molecular weight immediately above 75kDa-heavy chain.
DISCUSSION
The observations here reported indicated that complexed IgG anti-IgE might be detected in high concentration in sera from VL patients. These immune complexes are not increased in sera from patients suffering from hepatic-intestinal schistosomiasis mansoni, and their titers were not correlated with the elevated concentration of serum IgE presented by some infected patients. On the other hand, sera from schistosomiasis group presented the same reactivity pattern for IgG anti-IgE observed in sera from healthy controls, which had IgE concentration below 150 IU/ml. This argues against the participation of polyclonal B-cell activation in the production of IgG anti-IgE autoantibodies and indicates that the biological significance of the increased levels of IgG anti-IgE autoantibodies needs to be elucidated. According to previous hypothesis IgG anti-IgE autoantibodies may exert the role of specific feed back molecules that neutralize the IgE immune response induced by the cytokine network (Stadler et al. 1993a) . IgG anti-IgE autoantibodies are a heterogeneous population of antibodies that execute functions of physiological control of the specific IgE Th2 immune response, as inhibition of IgE synthesis and removal of IgE from CD23 receptor (Stadler et al. 1993b ). In atopic diseases as asthma these autoantibodies have been implicated in the modulation of the IgE immune response, mainly because they may react with epitopes located in C epsilon 2 domain of IgE, which is involved in the binding of this immunoglobulin on Fcε high affinity receptor (FcεRI) on the surface of basophils and mast cells, preventing the sensitization of these cells (Shakib & Powell-Richards 1991 , Stadler et al. 1995 .
Immunoblotting analysis carried out with material eluted from Sepharose-protein G beads used in serum IgG depletion confirmed the presence of IgG anti-IgE autoantibodies in all sera tested and evidenced significant cleavage of IgE under physiologic conditions. A frequent 75 kDa Mr band corresponding to IgE ε-heavy chain and polypeptides of different size, all carrying ε-heavy chain epitopes, were revealed with specific goat IgG anti-human IgE peroxidase conjugate in the blots carried out with sera from the three groups, including healthy control sera. Apparently, such pattern of IgE degradation may reflect the action of intrinsic regulatory mechanisms used by the organism to block the formation of circulating immune complexes with IgG anti-IgE autoantibodies, avoiding therefore inflammation and autoimmunity. The observation of an unusual fragment of IgE only in VL sera needs to be investigated. Current studies are evaluating the participation of L. chagasi proteases in enzymatic digestion of this immunoglobulin during infection, after binding to CD23 receptor on parasited macrophages.
The information that IgG anti-IgE autoantibodies contribute significantly for serum immunoglobulin E loss in laboratory procedures of immunoglobulin G depletion using immobilized specific ligands is a relevant subject in immunodiagnosis assays. The main consequence of this sequestration of immune complexes formed by IgG and IgE, is an accentuated fall in sensitivity of the immunoassays projected to detect specific serum IgE antibodies in vitro and consequently occurrence of false negative results. Additionally, this finding determine caution during the interpretation of IgG antibody positive tests obtained with solid phase immunoassays covered with immobilized antigens and sera presenting concomitant high concentrations of IgE specific antibodies and IgG anti-IgE autoantibodies, as observed in Th2 immune responses from allergic or parasitic diseases.
